|
| |||||||||||||||||||||||||||||||||||
We report on two women (58 and 81 years of age) who presented with anaphylaxis a few minutes after ingesting a generic omeprazole capsule.4,5 In both women the systolic blood pressure fell to less than 90, and both had sudden onset of difficulty breathing. Both women had previously taken nongeneric omeprazole and had not had a reaction. The generic drug that each of the women took contained approved soybean oil as an excipient. After the women provided written informed consent, skin-prick tests and soybean-specific IgE assays (ImmunoCAP assay, Phadia) were performed. Patient 1 had a wheal diameter of 20 mm after the injection of soybean extract (ALK-Abelló) and a wheal diameter of 14 mm after the injection of the powder contained in a capsule of generic omeprazole diluted 1:10 in 0.9% saline solution; her soybean-specific IgE level was 9.01 kU per liter. Patient 2 had a wheal diameter of 14 mm after the injection of soybean extract and of 12 mm after the injection of the powder contained in generic omeprazole; her soybean-specific IgE level was 23 kU per liter.
The skin-prick tests for nongeneric omeprazole were negative in the 2 patients and in 10 controls without atopy. The skin-prick tests for generic omeprazole extract were positive in five patients who were sensitized to soybean (wheal diameter, 10 mm).
An IgE dot blot (Bio-Rad) was performed on the powder contained in generic omeprazole capsules from two manufacturers, on the powder in nongeneric omeprazole capsules reconstituted in 20% ethanol and 80% water, on soybean extract, and on soybean oil. The serum from the two patients showed a positive response to the generic omeprazole produced by each of the two manufacturers, to soybean oil, and to soybean extract but a negative reaction to diluent control wells and to nongeneric omeprazole. The serum from nonatopic controls did not react to any of the products tested (Figure 1).
|
Antonio Dueñas-Laita, M.D., Ph.D.
Rio Hortega University Hospital
Valladolid, Spain
Fernando Pineda, D.Pharm., Ph.D.
Diater Laboratories
Madrid, Spain
Alicia Armentia, M.D., Ph.D.
Rio Hortega University Hospital
Valladolid, Spain
aliciaarmentia{at}gmail.com
Dr. Pineda reports being an employee of Diater Laboratories, which specializes in the manufacture of specific immunotherapy with allergens. No other potential conflict of interest relevant to this letter was reported.
| |||||||||||||||||||||||||||||||||||
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |